Home > Products > Featured products
Cat. No. Product name CAS No.
DC24054 Poloxime Featured

An analog of thymoquinone that blocks pSer/pThr recognition by Plk1 Polo-box domain as a phosphate mimic..

17302-61-3
DC26076 D-Ala2, D-Leu5-Enkephalin Featured

An angiotensin II analog that is an agonist of AT1 angiotensin receptor..

64963-01-5
DC22604 Anisomycin Featured

An antibiotic that inhibits eukaryotic protein synthesis by inhibiting peptidyl transferase or the 80S ribosome system.

22862-76-6
DC25077 Naphthoquine phosphate Featured

Naphthoquine phosphate is a potent and orally active antimalarial agent. Naphthoquine phosphate has thorough killing function for various schizonts of plasmodia, including resistance of P. falciparum to Chloroquine.

173531-58-3
DC10594 Tolcide 2230 Featured

An antimicrobial agent used as a substitute for chlorophenols

21564-17-0
DC22497 MMAF-OMe Featured

MMAF-Ome belongs to ADC, and inhibits several tumor cell lines with IC50s of 0.056 nM, 0.166 nM, 0.183 nM, and 0.449 nM for MDAMB435/5T4, MDAMB361DYT2, MDAMB468, and Raji (5T4-) cell lines, respectively.

863971-12-4
DC11575 E3 Ligand-Linker Conjugate 9 Featured

An E3 ligase ligand-linker conjugate for PROTAC.

1957236-20-2
DC11572 E3 Ligand-Linker Conjugate 6 Featured

An E3 ligase ligand-linker conjugate for PROTAC..

2022182-57-4
DC11573 E3 Ligand-Linker Conjugate 7 Featured

An E3 ligase ligand-linker conjugate for PROTAC..

2022182-59-6
DC11574 E3 Ligand-Linker Conjugate 8 Featured

An E3 ligase ligand-linker conjugate for PROTAC..

1957235-74-3
DC22869 E3 Ligand-Linker Conjugate 3(E3 Ligase Ligand-Linker Conjugates 19) Featured

An E3 ligase ligand-linker conjugate for PROTAC.

1799711-24-2
DC26084 LE-135 Featured

LE135 is a retinoid acid receptor antagonist, produces pain through direct activation of TRP channels.

155877-83-1
DC24168 (R)-(-)-Ibuprofen Featured

An enantiomer of Ibuprofen that is generally not considered a COX inhibitor and is instead thought to be involved in pathways of lipid metabolism as it is incorporated into triglycerides along with fatty acids.

51146-57-7
DC23914 Thymalfasin Featured

An immunoactive peptide that has been shown to inhibit cell proliferation and induce apoptosis in human leukemia, non-small cell lung cancer, melanoma, and other human cancers.

62304-98-7
DC1001 FK-506 (Tacrolimus) Featured

An immunosuppressive agent and macrolide antibiotic.

104987-11-3
DC22995 IRES-J007 Featured

IRES-J007 ia an improved IRES inhibitor that blocks IRES-hnRNP A1 binding; binds to a small pocket structure within the RRM-containing fragment of hnRNP A1 (UP1 fragment), inhibits cyclin D1 and c-MYC IRES activity to a greater extent compared with C11 (IRES-C11); significantly reduces tumor growth of GBM xenografts in mice, and markedly reduces the mRNA translational state of cyclin D1 and c-MYC transcripts combined with PP242.

155514-72-0
DC6311 Pomalidomide Featured

An inhibitor of LPS-induced TNFαrelease.Pomalidomide is thalidomide derivative that displays inhibition of LPS-induced TNFα release. Shows immunomodulator and anticancer effects.

19171-19-8
DC24177 Mitiglinide calcium hydrate Featured

An insulin secretion stimulator by closing the ATP-sensitive potassium KATP channels in pancreatic β cells.

207844-01-7
DC22612 Afatinib Featured

An irreversible, dual EGFR/HER2 inhibitor with IC50 of 0.5/0.4/10/14 nM for wt EGFR/EGFR L858R/EGFR L858R+T790M/HER2 respectively.

850140-72-6
DC11640 PK-11195 Featured

PK 11195 is a ligand of translocator protein. It targets Leishmania chemotherapy (IC50s of 14.2 μM, 8.2 μM, 3.5 μM for L. amazonensis, L. major and L. braziliensis, respectively).

85532-75-8
DC11911 Rovazolac Featured

Rovazolac is a liver x receptor (LXR) modulator extracted from patent WO2013130892A1.

1454288-88-0
DC24069 CI-947 Featured

An orally active adenosine receptor agonist that can induce acute cardiovascular toxicity and coronary vascular injury in vivo..

96392-15-3
Page 32 / Total 440 FirstPrevNextLastGoto